What are the differential diagnoses for blisters on the lower extremities?

Differential Diagnoses for Blisters on the Lower Extremities

The differential diagnosis for lower limb blisters should be systematically approached by categorizing based on blister level (subcorneal, intraepidermal, or subepidermal), distribution pattern, associated features, and patient demographics to distinguish between life-threatening conditions requiring immediate intervention and self-limited processes.

Life-Threatening Conditions Requiring Immediate Recognition

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

• Characterized by widespread epithelial keratinocyte apoptosis with flaccid bullae, painful skin, and multisite mucositis 1
• Mortality ranges from <10% for SJS to 30% for TEN 1
• Clinical phenotypes based on body surface area (BSA) involvement: SJS (<10% BSA detachment), overlap SJS-TEN (10-30% BSA), TEN (>30% BSA) 1
• Positive Nikolsky sign (epidermis slides with lateral pressure) is a helpful clinical indicator 1
• Early lesions appear as atypical targets and purpuric macules, commonly starting on upper torso, proximal limbs, and face, with prominent involvement of palms and soles 1
• Immediate discontinuation of culprit drug is essential - usually anticonvulsants or antibiotics in children, various medications in adults 1
• Histology shows variable epidermal damage from individual cell apoptosis to confluent necrosis with subepidermal vesicle formation 1

Autoimmune Blistering Disorders

Bullous Pemphigoid (BP)

• Most common autoimmune blistering disease in elderly patients, presenting with tense bullae on erythematous or normal skin 1
• Symmetrical distribution over flexural surfaces of limbs, inner thighs, and trunk 1
• Diagnosis requires linear IgG and/or C3 deposits along dermoepidermal junction on direct immunofluorescence (DIF) 1
• Histology demonstrates subepidermal bullae with eosinophils and/or neutrophils 1
• Mortality rates vary between 6-41%, primarily due to elderly age and comorbidities 1
• Nikolsky sign is negative (distinguishing from pemphigus and SJS/TEN) 1

Pemphigus Vulgaris

• Presents with flaccid bullae that rupture easily, leaving painful erosions 1
• Positive Nikolsky sign in active disease 1
• Intraepidermal blistering with acantholysis on histology 1
• DIF shows intercellular IgG deposition in epidermis 1
• Lower extremity involvement less common than trunk and mucous membranes 1

Epidermolysis Bullosa Acquisita (EBA)

• Subepidermal blistering disorder with trauma-induced blisters on extensor surfaces 2, 3
• DIF shows linear IgG at dermoepidermal junction, but on dermal side of salt-split skin (distinguishing from BP) 2
• Chronic course with scarring and milia formation 2

Linear IgA Dermatosis

• Subepidermal blistering with linear IgA deposits on DIF 2, 3
• Can present with "string of pearls" configuration of vesicles 3
• May be drug-induced or idiopathic 3

Infectious Causes

Impetigo Contagiosa

• Most common vesicle-forming disease in children 4
• Subcorneal blisters with honey-colored crusting 4
• Caused by Staphylococcus aureus or Streptococcus pyogenes 4
• Responds to topical or systemic antibiotics 4

Herpes Simplex/Varicella-Zoster

• Grouped vesicles on erythematous base 1
• Painful in herpes zoster, following dermatomal distribution 1
• Viral culture or PCR confirms diagnosis 1

Necrotizing Bacterial Infections

• Rapidly progressive with systemic toxicity 1
• Requires urgent surgical debridement and antibiotics 1

Metabolic and Vascular Causes

Bullosis Diabeticorum

• Spontaneous, non-inflammatory blisters in poorly controlled diabetes mellitus 5
• Typically on feet and lower legs 5
• Painless blisters that rupture spontaneously 5
• Histology shows dermal-epidermal separation; DIF usually negative (though IgG deposition in capillary basement membrane reported) 5
• Heals with aggressive wound care over weeks to months 5

Venous Ulcers with Blistering

• Develops in regions of chronic venous disease above medial malleolus 1
• Typically wet lesions with surrounding skin changes (hemosiderin deposition, lipodermatosclerosis) 1
• Associated with venous hypertension 1

Peripheral Artery Disease (PAD)

• Dry, painful ulcers on toes and pressure points 1
• Abnormal ankle-brachial index (<0.90) or toe-brachial index (≤0.70) 1
• Requires vascular assessment and revascularization 1

Inflammatory Dermatoses

Erythema Multiforme Major (EMM)

• Distinguished from SJS by typical or raised atypical targets predominantly on limbs and extremities 1
• Mucous membrane involvement with <10% BSA epidermal detachment 1
• Usually triggered by herpes simplex virus, rarely drugs (opposite of SJS/TEN) 1

Erythema Nodosum

• Raised, tender, red/violet subcutaneous nodules 1-5 cm diameter 1
• Commonly affects anterior tibial areas 1
• Associated with inflammatory bowel disease, infections, medications 1
• Histology shows focal panniculitis 1

Pyoderma Gangrenosum

• Begins as erythematous papules/pustules, progresses to deep excavating ulcerations 1
• Commonly on shins and adjacent to stomas 1
• Pathergy phenomenon (trauma-induced lesions) 1
• Associated with inflammatory bowel disease in 0.6-2.1% of patients 1

Other Important Differentials

Porphyria Cutanea Tarda

• Blisters on sun-exposed areas (dorsal hands/feet) 2, 3
• Skin fragility, hypertrichosis, hyperpigmentation 2
• Elevated urine porphyrins confirm diagnosis 3

Fixed Drug Eruption

• Recurrent blisters at same site with drug re-exposure 1
• Hyperpigmentation after healing 1

Contact Dermatitis (Severe)

• Vesicles/bullae at site of allergen contact 6
• Pruritic with eczematous features 6
• Patch testing identifies allergen 6

Diagnostic Algorithm

Step 1: Assess for life-threatening features

• Extensive skin involvement (>10% BSA), mucosal involvement, systemic symptoms, positive Nikolsky sign → Consider SJS/TEN; discontinue all potential culprit drugs immediately 1

Step 2: Determine blister characteristics

• Tense vs. flaccid bullae 1
• Distribution pattern (flexural, extensor, acral, dermatomal) 1, 2
• Associated features (targets, purpura, urticaria, scarring) 1

Step 3: Obtain diagnostic specimens

• Skin biopsy from early intact blister for histology (formalin) 1
• Perilesional skin biopsy for DIF (Michel's medium or fresh frozen) 1
• Blood for indirect immunofluorescence and ELISA (BP180, BP230 antibodies) 1

Step 4: Consider patient demographics and comorbidities

• Age >70 years → BP more likely 1
• Poorly controlled diabetes → bullosis diabeticorum 5
• Recent medication changes → drug-induced blistering 1
• Inflammatory bowel disease → pyoderma gangrenosum, erythema nodosum 1

Step 5: Evaluate for underlying systemic disease

• Vascular assessment (ABI/TBI) if ulceration present 1
• Metabolic workup (glucose, renal function) 1, 5
• Infection screening (bacterial culture, viral PCR) 1

Critical Pitfalls to Avoid

• Do not delay discontinuation of suspected culprit drugs in SJS/TEN - mortality increases with continued exposure 1
• Do not assume negative DIF excludes autoimmune blistering - specimen must be from perilesional skin, not blister roof 1
• Do not confuse paracetamol/ibuprofen use for prodromal symptoms as causative agents in SJS/TEN - these are likely confounders, though rare causative cases reported 1
• Do not overlook noncompressible vessels in diabetes/CKD - falsely elevated ABI >1.4 requires toe-brachial index for PAD assessment 1
• Do not deroof intact blisters - pierce at base to drain while leaving roof as biological dressing 1